Brief: Isofol Medical Strengthens Patent Protection For Arfolitixorin In Japan
Sept 1 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST :
* STRENGTHENED PATENT PROTECTION FOR ARFOLITIXORIN IN JAPAN
* OBTAINING TWO NEW PATENT GRANTS FOR ARFOLITIXORIN IN JAPAN
* TOGETHER WITH ALREADY GRANTED ACTIVE SUBSTANCE PATENT
(API),
THESE TWO PATENTS WILL ENSURE A STRONG AND EXTENDED PATENT
PROTECTION FOR IMPORTANT FUTURE JAPANESE MARKET UNTIL 2038
Source text for Eikon: ID:nWkr7CtLyN
Further company coverage: ISOFOL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Isofol Medical AB (publ)
See all newsSweden's Isofol Medical Q1 net loss widens, raises funds
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million
Brief: Isofol Medical Announces Bfarm Approval Of Optimized Phase Ib/Ii Study Design
Brief: Isofol Gets Gross Proceeds Of SEK 18.9 Mln In Connection With Exercise Of Warrants And Guarantee Commitments
Brief: Isofol Secures License Rights For Arfolitixorin In Autism